Please provide your email address to receive an email when new articles are posted on . In patients with chronic coronary disease, the beneficial effects of colchicine were consistent regardless of ...

Investigators report that regardless of when the event happened—in the last 6 to 24 months or more than 7 years ago—colchicine effectively lowered the risk of major cardiovascular events compared with ...

"The amount of data obtained are overwhelming and will need careful interpretation due to the study's significant implications, which may change the way adjuvant anticoagulation is given to ACS ...

The benefits of low-dose colchicine (Colcrys) are consistent if started months or years after acute coronary syndrome (ACS) in patients with stable coronary artery disease, a new LoDoCo2 subanalysis ...